Parameters influencing the stealthiness of colloidal drug delivery systems.
about
Anti-PEG immunity: emergence, characteristics, and unaddressed questions.Stealth Properties to Improve Therapeutic Efficacy of Drug NanocarriersPre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategyAutophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicityTranslocation of PEGylated quantum dots across rat alveolar epithelial cell monolayersBarriers to inhaled gene therapy of obstructive lung diseases: A reviewAllergic Responses Induced by the Immunomodulatory Effects of Nanomaterials upon Skin ExposureLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Nanoparticle mediated drug delivery of rolipram to tyrosine kinase B positive cells in the inner ear with targeting peptides and agonistic antibodies.Effect of surface architecture on in vivo ultrasound contrast persistence of targeted size-selected microbubbles.A stimulus-responsive contrast agent for ultrasound molecular imaging.PEGylated graphene oxide elicits strong immunological responses despite surface passivation.Potential novel drug carriers for inner ear treatment: hyperbranched polylysine and lipid nanocapsules.Nanoparticle targeting to diseased vasculature for imaging and therapy.Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes.Positively-charged, porous, polysaccharide nanoparticles loaded with anionic molecules behave as 'stealth' cationic nanocarriersPoly(lactic acid)-poly(ethylene glycol) nanoparticles provide sustained delivery of a Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice.Sensing surface PEGylation with microcantileversHollow poly(MPC-g-PEG-b-PLA) graft copolymer microcapsule as a potential drug carrier.Paclitaxel and iron oxide loaded multifunctional nanoparticles for chemotherapy, fluorescence properties, and magnetic resonance imaging.Optimization of PEGylation conditions for BSA nanoparticles using response surface methodology.Summary report of PQRI Workshop on Nanomaterial in Drug Products: current experience and management of potential risks.A quantitative recipe for engineering protein polymer nanoparticles.Preliminary biocompatibility investigation of magnetic albumin nanosphere designed as a potential versatile drug delivery system.Evaluation of drug loading, pharmacokinetic behavior, and toxicity of a cisplatin-containing hydrogel nanoparticle.Bacterial Magnetosome: A Novel Biogenetic Magnetic Targeted Drug Carrier with Potential Multifunctions.Novel drug delivery system based on docetaxel-loaded nanocapsules as a therapeutic strategy against breast cancer cellsEvaluation of the efficiency of tumor and tissue delivery of carrier-mediated agents (CMA) and small molecule (SM) agents in mice using a novel pharmacokinetic (PK) metric: relative distribution index over time (RDI-OT).The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate.Single-Step Assembly of Multimodal Imaging Nanocarriers: MRI and Long-Wavelength Fluorescence Imaging.PEG-b-AGE Polymer Coated Magnetic Nanoparticle Probes with Facile Functionalization and Anti-fouling Properties for Reducing Non-specific Uptake and Improving Biomarker Targeting.Synthesis and in vivo pharmacokinetic evaluation of degradable shell cross-linked polymer nanoparticles with poly(carboxybetaine) versus poly(ethylene glycol) surface-grafted coatings.Recent Advances in Targeted, Self-Assembling Nanoparticles to Address Vascular Damage Due to Atherosclerosis.Biomaterial Strategies for Immunomodulation.PEGylation as a strategy for improving nanoparticle-based drug and gene deliveryBiodistribution and fate of core-labeled 125I polymeric nanocarriers prepared by Flash NanoPrecipitation (FNP).Biological evaluation of pH-responsive polymer-caged nanobins for breast cancer therapyNanoemulsion loaded with lycobetaine-oleic acid ionic complex: physicochemical characteristics, in vitro, in vivo evaluation, and antitumor activityNanoparticle characterization: state of the art, challenges, and emerging technologies.Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
P2860
Q26825556-3D6043BC-D5B7-4651-864A-FBF09B443020Q27496024-803FE028-53C8-4CBF-A602-34CA043D1EA9Q28081577-FF92C49E-3B3D-44B2-BD40-F4B3451F2F76Q28388552-0C01F3B2-1E1C-4E85-9AE7-06F8B5E69669Q28394182-5EC5B38C-69DA-4A54-B864-52594062C573Q29248141-0FD87280-0154-4F71-8EBE-07BF40A5A5B1Q29248341-7FB791B4-97CF-4D3B-963F-49D32C0A90D2Q30366990-72535E39-1BB1-4B9A-AC2E-9D4648779A37Q30409983-DECEC50D-D544-408D-834C-4ACE85031ABCQ30457849-C860838D-7D88-4063-A4F2-E1E2FB90621CQ30491503-A24C2F81-3946-4E3F-893A-AA34E56E5745Q30840337-EE35644F-BF9F-44E3-990A-74E7B1546AB2Q33491736-882CF747-7BE7-434C-90A2-8C4AA2C9B263Q33831738-DB2B5A28-56C4-4CF4-8C61-4B261E97BF30Q33838871-D84EE1E0-C19B-43A4-ACB6-C2553D03BF9CQ33982639-4723D313-0775-4B82-84D6-387CCB6CAF43Q33993714-B7CBBAD3-748B-4F9A-BC88-5570744F5696Q34041630-4390FEB2-C835-452D-8105-4BA20ACF7637Q34116291-71BC2244-71CA-4458-AE8C-6AFD4F3CD0E1Q34177922-4A79F159-57A0-4295-88BF-DA727947DD44Q34280232-E4F03D98-F9A4-443D-AFE9-FE117B1CDE64Q34871881-6B544B0C-1831-4A20-A46A-CDEB48C04630Q35089738-623A47B1-E040-46D1-A1D5-271A08D1BF7EQ35254404-689C6C58-0D1E-4367-A377-0311465A3C21Q35551143-004C29AC-EA78-4C2C-B6BF-245BCABBD7ABQ35846813-8584D857-2988-47BC-838F-C9E2D9C6B6B0Q35934052-AEA54117-A080-4FFF-819A-6CD8583F4EECQ36071814-C4526234-6545-4A8D-8B42-C8F2B54A7F48Q36129610-B0A62E0C-58D0-42E3-A48E-3CB4F44A02C2Q36198686-F0FF9B63-86D9-4EA8-ACF2-663BAC425C4AQ36299217-B7D0BBFC-2763-4B02-A06D-00E607B9A6F6Q36361709-A450465F-CD1A-4B81-A4B8-9F67E4A6FDCEQ36598388-F4EF8868-FBB5-44EB-A760-AFCA6BEE8423Q36703124-AE079B56-6CFB-4A52-973A-E80D85F6A725Q36703361-581120DF-A564-4D83-9375-3766B8E4E404Q36783691-3FE2D870-0057-4DAF-B529-DA7E5B7297C5Q36831957-515F1E35-E873-4800-A1D9-093F89E7C41DQ36883923-6EBB8FE0-66CD-4776-93BE-6CBB9942663DQ36901928-F4D51CE9-7262-4B21-83FF-F7C3763F4D74Q36934007-69ED2131-ABDD-40CE-9807-78B232F8A6A8
P2860
Parameters influencing the stealthiness of colloidal drug delivery systems.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Parameters influencing the stealthiness of colloidal drug delivery systems.
@ast
Parameters influencing the stealthiness of colloidal drug delivery systems.
@en
type
label
Parameters influencing the stealthiness of colloidal drug delivery systems.
@ast
Parameters influencing the stealthiness of colloidal drug delivery systems.
@en
prefLabel
Parameters influencing the stealthiness of colloidal drug delivery systems.
@ast
Parameters influencing the stealthiness of colloidal drug delivery systems.
@en
P2093
P1433
P1476
Parameters influencing the stealthiness of colloidal drug delivery systems.
@en
P2093
Arnaud Vonarbourg
Catherine Passirani
Jean-Pierre Benoit
Patrick Saulnier
P304
P356
10.1016/J.BIOMATERIALS.2006.03.039
P577
2006-05-02T00:00:00Z